Exhibit 99.1

FOR IMMEDIATE RELEASE

Contacts:

SURGICAL CARE AFFILIATES, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2014 RESULTS

DEERFIELD, IL – March 10, 2015 – Surgical Care Affiliates, Inc. (NASDAQ: SCAI) (“SCA” or the “Company”) announced today results for the fourth quarter of 2014, including: 15.6% growth in Net operating revenues (to $247.2 million), 26.0% growth in Adjusted EBITDA less NCI (to $48.0 million), and Net income attributable to SCA of $17.9 million. For the full year, the Company’s adjusted EBITDA less NCI grew 10%, which was consistent with its original guidance. The Company has added ten new facilities since the end of the third quarter of 2014, including four added since the beginning of 2015, and reiterated its previous guidance of 8% to 11% growth in EBITDA less NCI for 2015.

“We continue to achieve strong clinical quality outcomes based on National Quality Forum endorsed metrics as well as strong patient satisfaction results. From a financial standpoint, our fourth quarter results contributed to making 2014 our sixth consecutive year of approximately ten percent growth in adjusted EBITDA less NCI, consistent with original guidance,” said Andrew Hayek, President & CEO. “Our strategic partnerships with health systems and major physician groups position us to continue our growth trajectory in 2015.”

Strategic Transactions and Facility Count Update

During the fourth quarter of 2014, the Company added six facilities, three of which were consolidated, two of which were non-consolidated, and one that was managed-only. One facility was converted from consolidated to a non-consolidated investment, which did not have an impact on facility count. Additionally, as part of the Company’s ongoing effort to optimize its portfolio, the Company merged one facility and closed one non-strategic facility. As of December 31, 2014, the Company had 186 facilities, up from 182 at September 30, 2014.  Since the end of 2014, the Company has added four additional facilities, bringing its total facility count to 190 as of March 10^th, 2015.  

Many of these facilities are in partnership with major physician groups and in affiliation with the Company’s current count of 43 health system partners across the country, including the fourteenth facility with Indiana University Health and the eleventh facility with Texas Health Resources.      

On March 9, 2015 the Company announced its intention to replace its existing senior credit facility, which consists of $596 million of term loan facilities and a $132 million revolving credit facility, with a proposed new senior secured credit facility of up to $700 million in aggregate principle amount, and $250 million of senior unsecured notes.  This new capital structure will increase liquidity, reduce its senior secured debt, extend its debt maturities, and generally increase the Company’s financial flexibility as it continues to carry out its growth strategy.

Fourth Quarter Results

Total net operating revenues, which exclude revenues from facilities in which SCA owns a non-controlling interest, increased 15.6% in the fourth quarter of 2014 to $247.2 million from $213.8 million in the prior year period. This increase was driven by revenues

earned from acquisitions, higher acuity case mix and increased rates paid under certain payer contracts, partially offset by the deconsolidation of one facility during the fourth quarter.

Systemwide net operating revenues, which include revenues from all facilities in which SCA has an ownership interest (without adjustment based on SCA’s percentage of ownership) and management fee revenues from managed-only facilities, increased 9.9% in the fourth quarter as compared to the prior year period.  On a same site basis, systemwide net operating revenue for the fourth quarter of 2014 increased 4.7% over the fourth quarter of 2013. Same site systemwide net patient revenue per case increased 4.1% in the fourth quarter of 2014 over the prior year period, and same site systemwide case volume was approximately flat in the fourth quarter of 2014 compared to the prior year period. The growth in systemwide revenue metrics was largely driven by higher acuity case mix and investments in facilities.

Net income attributable to SCA, which includes certain non-cash and non-recurring expenses, was $17.9 million for the fourth quarter of 2014, compared to a net loss attributable to SCA of $27.4 million for the fourth quarter of 2013.  Adjusted net income, which adjusts for items that are non-cash or non-recurring in nature, increased 58.5% for the fourth quarter of 2014 to $27.9 million from $17.6 million for the same period of the prior year.

Adjusted EBITDA less NCI, which adds back certain non-recurring expenses, increased 26.0% for the fourth quarter of 2014 to $48.0 million from $38.1 million in the same period of the prior year.

SCA’s cash flow from operating activities was $54.4 million for the three months ended December 31, 2014, up 56.3% from the fourth quarter of 2013. Operating cash flow less distributions to non-controlling interests was $22.8 million during the fourth quarter of 2014, an increase of 105.4% from $11.1 million in the same period of the prior year.

Full Year 2014

Total net operating revenues, which exclude revenues from facilities in which SCA owns a noncontrolling interest, increased 10.1% for full year 2014 to $864.7 million from $785.7 million in 2013. This increase was driven by revenues earned from acquisitions, higher acuity case mix and increased rates paid under certain payor contracts, partially offset by the deconsolidation of two facilities and the disposition of two facilities since December 31, 2013.

Systemwide net operating revenues, which include revenues from all facilities in which SCA has an ownership interest (without adjustment based on SCA’s percentage of ownership) and management fee revenues from managed-only facilities, increased 10.0% in 2014.  For full year 2014, same site systemwide net operating revenue increased 3.1% from full year 2013. Same site systemwide net patient revenue per case grew 2.7% in 2014, compared to 2013. Same site systemwide case volume increased 0.2% in 2014. The growth in systemwide revenue metrics was largely driven by acquisitions, changes in case mix and increased earnings under certain payer contracts. The full year 2014 revenue metrics were impacted by the highly inclement and unusual winter weather experienced in some of the Company’s most concentrated markets during the first quarter of 2014.

Net income attributable to SCA, which includes certain non-cash and non-recurring expenses, was $32.0 million for full year 2014, compared to a net loss attributable to SCA of $51.3 million in 2013.  Adjusted net income, which adjusts for items that are non-cash or non-recurring in nature, increased 69.8% in 2014 to $81.5 million from $48.0 million the prior year.

Adjusted EBITDA less NCI, which adds back certain non-recurring expenses, increased 9.7% in 2014 to $156.7 million from $142.8 million in 2013.

SCA’s cash flow from operating activities was $210.6 million for 2014, up 27.2% from 2013. Operating cash flow less distributions to non-controlling interests was $97.1 million, an increase of 55.1% from $62.6 million the prior year.

Full Year 2015 Guidance

For 2015, the Company reiterates the guidance we initially established in January 2015. The Company continues to expect 2015 Adjusted EBITDA less NCI growth to be in the range of 8% to 11%.

Conference Call Information

SCA will hold a webcast conference call to discuss this release today at 8:00 a.m. EDT. The live webcast of the conference call will be available by accessing http://investor.scasurgery.com.  Following the call, an archived replay of the webcast will be available on the corporate website for 30 days.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements, which have been included in reliance of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, involve risks and uncertainties and assumptions relating to our operations, financial condition, business, prospects, growth strategy and liquidity, which may cause our actual results to differ materially from those projected by such forward-looking statements, and the Company cannot give assurances that such statements will prove to be correct. Investors are hereby cautioned that these statements may be affected by important factors, including, but not limited to, the following risks: our dependence on payments from third-party payers, including governmental healthcare programs, commercial payers and workers’ compensation programs; our inability or the inability of our healthcare system partners to negotiate favorable contracts or renew existing contracts with non-governmental third-party payers on favorable terms; significant changes in our payer mix or case mix resulting from fluctuations in the types of cases performed at our facilities; the fact that the Medicare and Medicaid programs provide a significant portion of our revenues and are each particularly susceptible to legislative and regulatory change; the implementation by states of reduced fee schedules and reimbursement rates for workers’ compensation programs; our inability to maintain good relationships with our current health system partners or our inability to enter into relationships with new health system partners; material changes in Internal Revenue Service revenue rulings, case law or the interpretation of such rulings; our dependence on physician utilization of our facilities, which could decrease if we fail to maintain good relationships with these physicians; the potential reduction in the number of surgical procedures because of physician treatment methodologies and governmental or commercial health insurance controls; our inability to attract new physician investors and to acquire and develop additional surgical facilities on favorable terms; shortages of, or quality control issues with, surgery-related products, equipment and medical supplies that could result in a disruption of our operations; the competition for staffing, shortages of qualified personnel or other factors that drive up labor costs; the intense competition we face for patients, physician use of our facilities, strategic relationships and commercial payer contracts; the fact that we are subject to significant malpractice and related legal claims, and we could be required to pay significant damages in connection with those claims; the adverse effect of current and future economic conditions on volume and case mix; the regulatory, economic and other conditions in certain states in which many of our facilities are concentrated; the fact that we have had a history of net losses and may not sustain profitability in the future; the fact that we may have a special legal responsibility to the holders of ownership interests in the entities through which we own our facilities, which may conflict with, and prevent us from acting solely in, our own best interest; the difficulty in operating and integrating newly acquired or developed facilities; the growth of patient receivables or the deterioration in the ability to collect on those accounts; the loss of the service of our senior management; our reliance on our private equity sponsor; our substantial indebtedness, and our ability to incur additional indebtedness in the future; our inability to generate sufficient cash in order to meet our debt service obligations; restrictions on our current and future operations because of the terms of our senior secured credit facilities; market risks related to interest rate changes; significant loans that we have made to the partnerships and limited liability companies that own and operate certain of our facilities; our liability for certain debt and other obligations of the partnerships and limited liability companies that own and operate certain of our facilities; recognition of impairment on our long-lived assets or equity method investments; our inability to manage and secure our information systems effectively, which could disrupt our operations; our inability to fully realize the value of our net operating loss carry-forwards; adverse impact of weather and other factors beyond our control on our facilities; our inability to predict the impact on us of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, which represents a significant change to the healthcare industry; our failure to comply with numerous federal and state laws and regulations relating to our facilities, which could lead to the incurrence of significant penalties by us or require us to make significant changes to our operations; our obligations to purchase some or all of the ownership interests of our physician partners or renegotiate some of our partnership and operating agreements because of changes to laws or regulations governing physician ownership of our facilities; our failure to comply with a federal criminal law referred to as the Anti-Kickback Statute or the physician self-referral laws; restrictions by federal law on our ability to expand surgical capacity of our surgical hospitals; our being subject to federal and state audits, investigations and lawsuits, including actions for false and improper claims; our failure to comply with Medicare’s conditions for coverage and conditions of participation, which could result in loss of program payment or other government sanctions; ensuring our continued compliance with the Health Insurance Portability and Accountability Act of 1996 or HIPAA, which could require us to expend significant resources and capital; our failure to effectively and timely implement electronic health records systems and transition to the ICD-10 coding system; efforts to regulate the

construction, relocation, acquisition, change of ownership, change of control or expansion of healthcare facilities, which could prevent us from acquiring additional facilities, renovating our existing facilities or expanding the breadth of services we offer; our being subject to enforcement action from antitrust authorities; our being subject to constantly evolving healthcare laws and regulations; the fact that we are a “controlled company” within the meaning of the NASDAQ Stock Market listing rules and as a result, we have previously utilized and may again utilize certain exemptions that would cause our stockholders to not have certain corporate governance protections concerning the independence of our board of directors and certain board committees that would otherwise apply to us; and the fact that our private equity sponsor has significant influence over us and key decisions about our business that could limit other stockholders’ ability to influence the outcome of matters submitted to stockholders for a vote.  Additionally, there is risk and uncertainty regarding whether SCA will be able to consummate the proposed refinancing transactions discussed in this press release.

The forward-looking statements made in this press release are made only as of the date of the hereof. Except as required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information or otherwise. More information about potential factors that could affect our business and financial results is included in our filings with the Securities and Exchange Commission, including in our most recent annual and quarterly reports on Form 10-K and Form 10-Q, respectively.

Legal Disclaimers

This announcement is neither an offer to sell nor a solicitation of an offer to buy the senior notes described herein. SCA plans to offer the senior notes in reliance upon an exemption from registration under the Securities Act of 1933, as amended (the "Securities Act"), for an offer and sale of securities that does not involve a public offering. The senior notes expected to be offered have not been and will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.

In addition, SCA cannot provide any assurances about the timing, terms or interest rate associated with the planned refinancing, or that the refinancing transactions can be completed at all. 

Use of Non-GAAP Financial Measures

In addition to the results prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) provided throughout this press release, SCA has presented the following non-GAAP financial measures, which management uses to gauge operating performance: Adjusted EBITDA less NCI, Adjusted net income (including basic Adjusted net income per share), and Operating cash flow less distributions to NCI. These non-GAAP financial measures exclude various items detailed in the attached “Reconciliation of Non-GAAP Financial Measures”.

These non-GAAP financial measures are not intended to replace financial performance measures determined in accordance with GAAP. Rather, they are presented as supplemental measures of the Company’s performance that management finds useful in assessing the Company’s operating performance between periods and that we believe are useful for investors to analyze our operating performance on the same basis as used by our management. You should be aware that there is no certainty that we will not incur expenses in the future that are similar to those excluded in the calculation of Adjusted EBITDA less NCI, Adjusted net income (including basic Adjusted net income per share) and Operating cash flow less distributions to NCI. Other companies in our industry may calculate Adjusted EBITDA less NCI, Adjusted net income (including basic Adjusted net income per share) and Operating cash flow less distributions to NCI differently than we do, limiting their usefulness as comparative measures. Because of these limitations, none of Adjusted EBITDA less NCI, Adjusted net income (including basic Adjusted net income per share) or Operating cash flow less distributions to NCI should be considered the primary measure of the operating performance of our business. We strongly encourage you to review the Company’s GAAP financial statements and not to rely on any single financial measure to evaluate our business.

As of December 31, 2014, 65 of SCA’s 186 facilities were nonconsolidated. SCA accounts for these facilities using the equity method. For consolidated subsidiaries, the Company’s financial statements reflect 100% of the revenues and expenses for these subsidiaries, after elimination of intercompany transactions and accounts. For nonconsolidated affiliates, our consolidated statements of operations reflect our earnings from such facilities in two line items:

• Equity in net income of nonconsolidated affiliates, which represents SCA’s combined share of the net income of each equity method facility that is based on such equity method facility’s net income and the percentage of such equity method facility’s outstanding equity interests owned by us; and

• Management fee revenues, which represents the Company’s combined income from management fees that are earned from managing the day-to-day operations of the facilities that are not consolidated for financial reporting purposes.

As a result of this accounting treatment in SCA’s reported results, management supplementally focuses on non-GAAP systemwide metrics to analyze the results of operations.  These systemwide metrics include systemwide net operating revenues growth, same site systemwide net operating revenues growth, systemwide net patient revenues per case growth, same site systemwide net patient revenues per case growth and same site systemwide case volume (day adjusted). Systemwide metrics treat SCA’s nonconsolidated facilities as if they were consolidated.  The Company includes management fee revenue from managed-only facilities in systemwide net operating revenues growth and same site systemwide net operating revenues growth, but not patient or other revenues from managed-only facilities (in which SCA holds no ownership interest). The Company does not include revenues from managed-only facilities in systemwide net patient revenues per case growth or same site systemwide net patient revenues per case growth. While net patient revenues earned at the nonconsolidated facilities are not recorded in our consolidated financial statements, management believes systemwide growth metrics are important to understand the Company’s financial performance because the metrics are used to interpret the sources of our growth and provide a growth metric incorporating the net patient revenues earned by all affiliated facilities, regardless of the accounting treatment.  As SCA executes on its strategy of partnering with health systems, management expects the number of our facilities accounted for as equity method facilities will increase relative to the total number of affiliated facilities.

About Surgical Care Affiliates

An industry leader, SCA partners with physicians, health systems and payers to develop and implement surgery strategies across the country. As of December 31, 2014, SCA operated 186 surgical facilities – including ambulatory surgery centers, surgical hospitals and one sleep center – in partnership with approximately 2,000 physicians and in affiliation with 42 health systems across the country. SCA's clinical systems, service line growth strategies, benchmarking processes and efficiency programs create measurable advantage for surgical facilities – clinically, operationally and financially. For more information on SCA, visit www.scasurgery.com.

Surgical Care Affiliates, Inc.

Unaudited Selected Financial and Operating Data

(In millions, except per share data)

Surgical Care Affiliates, Inc.

Unaudited Selected Financial and Operating Data, continued

(In millions, except number of shares in thousands and facility count)

Surgical Care Affiliates, Inc.

Supplemental Information

(Unaudited; in millions, except cases, growth rates and per share data)

Surgical Care Affiliates, Inc.

Reconciliation of Non-GAAP Financial Measures

(Unaudited; in millions, except per share count in thousands)